Trial Profile
A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Nov 2019
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cetuximab (Primary) ; Gefitinib
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 22 Oct 2005 New trial record.